AI-powered medical search engine that delivers synthesized, cited answers from peer-reviewed research for clinicians.
14M visits/mo+4.2%#2 Lifestyle & Education
Owkin
AI scientist for biopharmaceutical R&D decision-making and hypothesis generation
36KMonthly visits
26Popularity
About Owkin
K Pro is an AI scientist designed to automate and accelerate biopharmaceutical research and development. It operates by exploring and formulating hypotheses beyond human cognitive limits using advanced AI trained on multimodal patient data networks. The system continuously learns from real-world data, user feedback, and clinical validation, evolving toward fully automated research and development processes. Findings are refined through wet lab infrastructure and validated by a global network of oncologists and biologists, with results fed back to improve the AI’s capabilities. K Pro informs decision-making across clinical research, patient and population decisions, and early portfolio decisions in drug development. Its architecture aims to achieve true autonomy, described as a Biological Artificial SuperIntelligence capable of causal understanding of disease. The tool is positioned as a bridge between research and clinical care, providing insights in minutes rather than hours.
Owkin
Paris, France · Founded 2016
- Founded
- 2016
- Headquarters
- Paris, France
Key features
- Hypothesis generation beyond human cognitive limits
- Multimodal patient data network training
- Continuous learning from real-world data
- Wet lab infrastructure integration
- Clinical validation feedback loop
- Decision support for clinical research
- Patient and population decision insights
- Early portfolio decision guidance
Use cases
- Informing clinical trial decisions in drug development
- Generating insights for patient and population health decisions
- Supporting early portfolio decisions in biopharma R&D
Pros
- Trained on multimodal patient data networks
- Continuous learning from real-world data and clinical validation
- Integrates wet lab infrastructure for hypothesis refinement
- Designed for biopharmaceutical R&D decision-making
- Aims for causal understanding of disease through AI
Cons
- No explicit mention of pricing or free tier availability
- Limited detail on supported data types or integration methods
- Focus appears to be early-stage or proprietary use cases
Frequently asked questions about Owkin
What is Owkin's K Pro?
K Pro is an AI scientist designed to automate and accelerate biopharmaceutical research and development by exploring hypotheses beyond human cognitive limits using advanced AI trained on multimodal patient data networks.
Who is K Pro designed for?
K Pro is designed for biopharmaceutical researchers, clinicians, and decision-makers in drug development, clinical research, and patient care who need to generate insights and inform decisions across R&D processes.
How does K Pro work?
K Pro continuously learns from real-world data, user feedback, and clinical validation, refining its findings through wet lab infrastructure and a global network of oncologists and biologists, ultimately improving its own capabilities.
What are the key use cases for K Pro?
K Pro is used for clinical trial decisions, patient and population decisions, and early portfolio decisions in drug development, providing insights in minutes rather than hours.
Does K Pro integrate with existing systems?
K Pro is designed to connect research and clinical care, leveraging multimodal patient data networks and collaborating with global networks of experts, though specific integration details are tailored to each deployment.
How can I get started with K Pro?
Prospective users can book a demo with Owkin's team to explore how K Pro can be tailored to their specific research and development needs.
Owkin traffic & engagement
owkin.com · third-party estimates from Similarweb
Data as of Sep 2026Full AI website ranking →
Monthly visits · Sep 20260-10.8% MoM12-month high 77K (Jun 2026)
Rank among AI websites#2,864▼ 111 vs last monthof 8,384 tools on Aitoolnavio
Top marketFrance25.4%Top 5 countries bring 79% of visits
Average visit0sLonger than 66% of AI sites
Pages per visit0More than 59% of AI sites
Bounce rate0%Leave after one page · lower is better
Similarweb global rank#839,319#682,340 in United States
Traffic trend
Last 4 months · grows by one month every month
- Jun 202677K
- Jul 202670K−8.9%
- Aug 202640K−42.8%
- Sep 202636K−10.8%
Where visitors come from
Share of visits by channel
No measurable traffic from Social, Paid Referrals or Search.
Top countries
Share of visits · estimated visits
Other countries: 20.9%
Visits sent by AI assistants
How people reach this site from other AI tools
87 a month · 0.2% of all visits
Compared with similar tools
Lifestyle & Education · Sep 2026
Traffic figures are third-party estimates, good for scale and trends; they can differ from a company's own numbers. Updated monthly.
